Steve Hoang, PhD is the Head of Computational Biology at HemoShear Therapeutics. He completed his undergraduate and graduate studies at the University of Virginia, where he studied genomics and systems biology. He has spent the last ten years modeling biological networks and developing data analysis methods for genomic datasets. HemoShear leverages these computational methods along with state-of-the art human tissue models to understand disease biology. This research paradigm, which merges predictive modeling with experimental science, is used to discover novel therapies for a wide variety of diseases, including rare inborn errors of metabolism, gout, and fatty liver disease.